Steven Frank's Insider Trades & SAST Disclosures
Steven Frank's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 4,079 Automatic Stock Option Grant done . Disclosure was reported to the exchange on May 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven Frank.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc. | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 4,079 | 4,079 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 1,866 | 1,866 (0%) | 0% | 0 | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 87,412 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 87,412 | 1,140,307 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 83,517 | 83,517 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 71,839 | 71,839 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.74 per share. | 13 Mar 2025 | 28,735 | 1,052,895 (0%) | 0% | 1.7 | 49,999 | Common Stock |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 101,626 | 101,626 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 87,412 | 87,412 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.43 per share. | 14 Mar 2024 | 34,965 | 1,024,160 (0%) | 0% | 1.4 | 50,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 106,837 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 106,837 | 989,195 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 14 Aug 2023 | 400,000 | 882,358 (0%) | 0% | 1.7 | 688,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 125,489 | 125,489 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 106,837 | 106,837 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 1.17 per share. | 09 Mar 2023 | 42,735 | 482,358 (0%) | 0% | 1.2 | 50,000 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 61,576 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 61,576 | 439,623 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 16,212 | 378,047 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 16,212 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 83,189 | 83,189 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 61,576 | 61,576 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 22 Feb 2022 | 24,630 | 361,835 (0%) | 0% | 2.0 | 49,999 | Common Stock |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 22,107 | 22,107 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 16,212 | 16,212 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Grant, award, or other acquisition of securities at price $ 7.71 per share. | 25 Mar 2021 | 6,485 | 337,205 (0%) | 0% | 7.7 | 49,999 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2021 | 62,189 | 330,720 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2021 | 62,189 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 2,968 | 0 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.69 per share. | 03 Mar 2021 | 2,968 | 268,531 (0%) | 0% | 5.7 | 16,888 | Common Stock |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 2,968 | 0 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Steven Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.17 per share. | 30 Jun 2020 | 2,968 | 265,563 (0%) | 0% | 3.2 | 9,409 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges